ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $8.22M invested in Entero Therapeutics in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.28M

Top Sellers

1
-$730K
2
-$417K
3
-$364K
4
HCM
Highbridge Capital Management
New York
-$338K
5
BlackRock
BlackRock
New York
-$90K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.43M
2
$1.28M
3
$1.12M
4
$1.09M
5
$1.06M
6
$1.03M
7
$386K
8
$338K
9
$154K
10
$92K
11
$75K
12
$59K
13
$44K
14
$31K
15
$15K
16
$5K
17
$4K
18
$2K
19
–
20
–
21
–